BioXcel Therapeutics Inc (BTAI) — Defensive Interval Ratio
BioXcel Therapeutics Inc (BTAI) has a Defensive Interval Ratio of 1 days as of March 2026. Defensive assets of $216.00K (cash $-, short-term investments $-, receivables $216.00K) cover 1 days of daily cash needs of $150.67K/day. See BioXcel Therapeutics Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
BioXcel Therapeutics Inc Defensive Interval Ratio (2018–2025)
This chart shows how BioXcel Therapeutics Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2018 to 2025. As of March 2026, the ratio stands at 1 days, meaning defensive assets of $216.00K can fund 1 days of operations without new revenue. See BTAI net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for BioXcel Therapeutics Inc (2018–2025)
The table below presents the year-by-year Defensive Interval Ratio for BioXcel Therapeutics Inc from 2018 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see BTAI market cap.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2 days | $233.00K | $147.74K/day | $- | $- | ▼ -1 days |
| 2024 | 2 days | $131.00K | $60.91K/day | $- | $- | ▲ +1 days |
| 2023 | 1 days | $71.00K | $74.70K/day | $- | $- | ▼ -2 days |
| 2022 | 3 days | $248.00K | $90.13K/day | $- | $- | ▲ +3 days |
| 2021 | 0 days | $0.00 | $45.66K/day | $- | $- | ▼ -9 days |
| 2018 | 9 days | $115.00K | $12.77K/day | $- | $- | — |